tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate, 95.0%, 5g

(2R,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 98%, 250mg

(E)-Ethyl 2-methylbut-2-enoate, 97%, 100g

Microstamper libre de RNasa/DNasa, Gesch. para viales de reacción 0,5 ml 100 uds.

Fmoc-N-methyl-L-Phenylalanine, 97.0%, 1g

methyl 3-chloro-2-hydroxypropanoate, 250mg

(R)-4-(((9h-Fluoren-9-yl)methoxy)carbonyl)piperazine-2-carboxylic acid, 95%, 5g

Ethyl 5-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 1g

(11bR)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% 99%ee, 50mg

Tert-butyl3-hydroxy-3-[2-(trifluoromethyl)phenyl]azetidine-1-carboxylate, 98%, 500mg

(R)-4-N-Boc-2-hydroxymethyl-piperazine, 95.0%, 25g

7-Bromo-2,4-dichloro-8-fluoroquinazoline, 97%, 10g

N-methyl-2-(1H-pyrazol-4-yl)ethanamine dihydrochloride, 95.0%, 1g